The Selective Androgen Receptor Modulator GTx-024 (Enobosarm) Improves Lean Body Mass and Physical Function in Healthy Elderly Men and Postmenopausal Women: Results of a Double-Blind, Placebo-Controlled Phase II Trial

August 2011 in “ Journal of cachexia, sarcopenia and muscle ”

James T. Dalton, K. Gary Barnette, Casey E. Bohl, Michael L. Hancock, Domingo Rodriguez, Shontelle Dodson, Ronald A. Morton, Mitchell S. Steiner

GTx-024 enobosarm selective androgen receptor modulator lean body mass physical function insulin resistance total cholesterol HDL muscle wasting SARM muscle mass physical performance cholesterol high-density lipoprotein

TLDR Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

The study evaluated the effects of GTx-024 (enobosarm), a selective androgen receptor modulator, on lean body mass and physical function in 120 healthy elderly men and postmenopausal women over 12 weeks. Results showed that GTx-024 significantly increased lean body mass and improved physical function in a dose-dependent manner, with the 3 mg dose showing the most significant effects. Additionally, improvements in insulin resistance and reductions in total cholesterol and HDL were observed. The treatment was well tolerated, with adverse events similar between the GTx-024 and placebo groups. The findings suggested that GTx-024 could be beneficial in preventing or treating muscle wasting associated with chronic diseases.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

1 / 1 results

research In Vitro and In Vivo Structure-Activity Relationships of Novel Androgen Receptor Ligands with Multiple Substituents in the B-Ring

20 citations, September 2005 in “Endocrinology”

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Similar Research

5 / 25 results

research Selective Androgen Receptor Modulators Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial-Mesenchymal Stem Cell Signaling

56 citations, July 2014 in “PloS one”

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

research Emerging Medication for the Treatment of Male Hypogonadism

77 citations, May 2012 in “Expert Opinion on Emerging Drugs”

New treatments for male hypogonadism are effective and should be personalized.

Advances in Mitochondria-Centered Mechanism Behind the Roles of Androgens and Androgen Receptor in the Regulation of Glucose and Lipid Metabolism

research Advances in Mitochondria-Centered Mechanism Behind the Roles of Androgens and Androgen Receptor in the Regulation of Glucose and Lipid Metabolism

October 2023 in “Frontiers in endocrinology”

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

research Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents

90 citations, May 2019 in “Drugs”

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

research Androgen Receptor: A Promising Therapeutic Target in Breast Cancer

21 citations, March 2019 in “Critical Reviews in Clinical Laboratory Sciences”

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.